PE87598A1 - Derivados de lactona de 17�-carboxi, carbotio y amida androstano - Google Patents
Derivados de lactona de 17�-carboxi, carbotio y amida androstanoInfo
- Publication number
- PE87598A1 PE87598A1 PE1997000549A PE00054997A PE87598A1 PE 87598 A1 PE87598 A1 PE 87598A1 PE 1997000549 A PE1997000549 A PE 1997000549A PE 00054997 A PE00054997 A PE 00054997A PE 87598 A1 PE87598 A1 PE 87598A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- compound
- alkyl
- methyl
- carbothium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: R1 ES O, S o NH; R2 ES OC(=O)ALQUILO C1-C6, DE PREFERENCIA DICHO ALQUILO ES METILO, ETILO O N-PROPILO; R3 ES H, METILO (EL CUAL PUEDE ESTAR EN LA CONFIGURACION O o �) O ES METILENO; O R2 Y R3 JUNTOS REPRESENTAN (-O)(-O)CR6R7, EN DONDE R6 Y R7 SON H O ALQUILO C1-C6, DE PREFERENCIA SON H, METILO o N-PROPILO; R4 Y R5 SON H o HALOGENO, DE PREFERENCIA DICHO HALOGENO ES F; LAS LINEAS PUNTEADAS SON UN DOBLE ENLACE OPCIONAL. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE (I), QUE COMPRENDE: (A) TRATAR UN COMPUESTO DE FORMULA (II), EN DONDE "X" ES OH O UN DERIVADO ACTIVO DEL MISMO, CON UN COMPUESTO DE FORMULA (III), EN DONDE "Z" ES OH, NH2 O SH; O (B) TRATAR UN COMPUESTO DE FORMULA (II), EN DONDE "X" ES OH O SH, CON UN COMPUESTO DE FORMULA (VI), EN DONDE "Q" ES UN GRUPO DE SEPARACION TAL COMO Cl, Br o OSO2A, SIENDO "A" POR EJEMPLO CH3, CF3 o p-CH3C6H4, O CON UN COMPUESTO DE FORMULA (VII). LOS COMPUESTOS OBTENIDOS ACTUAN COMO AGONISTAS DEL ADRENORRECEPTOR �2, QUE POSEEN LA VENTAJA DE PRESENTAR POCO O NINGUN EFECTO SISTEMICO, SIENDO UTILES EN EL TRATAMIENTO INFLAMATORIO Y ALERGICO
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9526651.6A GB9526651D0 (en) | 1995-12-29 | 1995-12-29 | Compounds |
| GBGB9613121.4A GB9613121D0 (en) | 1996-06-21 | 1996-06-21 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE87598A1 true PE87598A1 (es) | 1999-01-15 |
Family
ID=26308402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000549A PE87598A1 (es) | 1995-12-29 | 1997-06-27 | Derivados de lactona de 17�-carboxi, carbotio y amida androstano |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6197761B1 (es) |
| EP (1) | EP0876392B1 (es) |
| JP (1) | JP2947944B2 (es) |
| KR (1) | KR19990076859A (es) |
| CN (1) | CN1133643C (es) |
| AP (1) | AP9801274A0 (es) |
| AT (1) | ATE194356T1 (es) |
| AU (1) | AU721865B2 (es) |
| BG (1) | BG102625A (es) |
| BR (1) | BR9612309A (es) |
| CA (1) | CA2241728A1 (es) |
| CZ (1) | CZ207498A3 (es) |
| DE (1) | DE69609199T2 (es) |
| DK (1) | DK0876392T3 (es) |
| EA (1) | EA001401B1 (es) |
| EE (1) | EE9800227A (es) |
| ES (1) | ES2150150T3 (es) |
| GR (1) | GR3034564T3 (es) |
| HK (1) | HK1012193A1 (es) |
| HU (1) | HUP9903707A3 (es) |
| IL (1) | IL124938A0 (es) |
| IS (1) | IS4781A (es) |
| MX (1) | MX9805181A (es) |
| NO (1) | NO311022B1 (es) |
| NZ (1) | NZ324373A (es) |
| OA (1) | OA10701A (es) |
| PE (1) | PE87598A1 (es) |
| PL (1) | PL327629A1 (es) |
| PT (1) | PT876392E (es) |
| SI (1) | SI0876392T1 (es) |
| SK (1) | SK89198A3 (es) |
| TR (1) | TR199801247T2 (es) |
| TW (1) | TW498072B (es) |
| WO (1) | WO1997024365A1 (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2215310T3 (es) * | 1997-06-30 | 2004-10-01 | Glaxo Group Limited | Procedimiento para identificar compuestos que tienen una actividad sistemica reducida. |
| GB9909229D0 (en) * | 1999-04-23 | 1999-06-16 | Glaxo Group Ltd | Enantiomers of mercapto lactones and processes for their synthesis |
| GB0017988D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Novel process |
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| EA005992B1 (ru) * | 2000-08-05 | 2005-08-25 | Глаксо Груп Лимитед | S-ФТОРМЕТИЛОВЫЙ ЭФИР 6α,9α-ДИФТОР-17α-[(2-ФУРАНИЛКАРБОНИЛ)ОКСИ]-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОКИСЛОТЫ В КАЧЕСТВЕ ПРОТИВОВОСПАЛИТЕЛЬНОГО АГЕНТА |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| AU2002253342B2 (en) * | 2001-04-30 | 2007-01-04 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
| ES2307751T3 (es) * | 2001-06-12 | 2008-12-01 | Glaxo Group Limited | Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano. |
| WO2003018575A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase |
| GB0125259D0 (en) | 2001-10-20 | 2001-12-12 | Glaxo Group Ltd | Novel compounds |
| WO2003042229A1 (en) * | 2001-11-12 | 2003-05-22 | Glaxo Group Limited | Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids |
| GB0127160D0 (en) * | 2001-11-12 | 2002-01-02 | Glaxo Group Ltd | Novel compounds |
| US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| AU2004226318B2 (en) * | 2003-04-04 | 2008-06-05 | Xellia Pharmaceuticals Aps | Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| EP1466920A1 (en) * | 2003-04-04 | 2004-10-13 | Alpharma APS | Process for the preparation of steroidal 17 beta-carbothioates |
| PT103202B (pt) | 2004-10-19 | 2011-01-27 | Hovione Farmaciencia S A | Processo para a esterificação de um ácido carbotiótico |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| AR059216A1 (es) * | 2006-01-27 | 2008-03-19 | Sun Pharmaceutical Ind Ltd | 11b-hidroxiandrosta-4-eno-3-onas |
| GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
| CN103087137A (zh) * | 2011-11-07 | 2013-05-08 | 天津金耀集团有限公司 | 一种21位为硫代烃基的糖皮质激素 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093721A (en) * | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
| US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
| SE8306370D0 (sv) * | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
| IL78144A0 (en) * | 1985-04-04 | 1986-07-31 | Draco Ab | Novel androstane-17beta-carboxylic acid esters |
| US5767113A (en) * | 1995-05-10 | 1998-06-16 | The Salk Institute For Biological Studies | Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance |
-
1996
- 1996-12-19 SK SK891-98A patent/SK89198A3/sk unknown
- 1996-12-19 DK DK96942493T patent/DK0876392T3/da active
- 1996-12-19 DE DE69609199T patent/DE69609199T2/de not_active Expired - Fee Related
- 1996-12-19 JP JP9524095A patent/JP2947944B2/ja not_active Expired - Fee Related
- 1996-12-19 IL IL12493896A patent/IL124938A0/xx unknown
- 1996-12-19 CN CNB961801077A patent/CN1133643C/zh not_active Expired - Lifetime
- 1996-12-19 CA CA002241728A patent/CA2241728A1/en not_active Abandoned
- 1996-12-19 CZ CZ982074A patent/CZ207498A3/cs unknown
- 1996-12-19 AT AT96942493T patent/ATE194356T1/de not_active IP Right Cessation
- 1996-12-19 PT PT96942493T patent/PT876392E/pt unknown
- 1996-12-19 KR KR1019980704986A patent/KR19990076859A/ko not_active Application Discontinuation
- 1996-12-19 TR TR1998/01247T patent/TR199801247T2/xx unknown
- 1996-12-19 WO PCT/GB1996/003140 patent/WO1997024365A1/en not_active Application Discontinuation
- 1996-12-19 EE EE9800227A patent/EE9800227A/xx unknown
- 1996-12-19 EA EA199800484A patent/EA001401B1/ru not_active IP Right Cessation
- 1996-12-19 BR BR9612309A patent/BR9612309A/pt not_active Application Discontinuation
- 1996-12-19 EP EP96942493A patent/EP0876392B1/en not_active Expired - Lifetime
- 1996-12-19 ES ES96942493T patent/ES2150150T3/es not_active Expired - Lifetime
- 1996-12-19 AU AU11409/97A patent/AU721865B2/en not_active Ceased
- 1996-12-19 SI SI9630232T patent/SI0876392T1/xx unknown
- 1996-12-19 NZ NZ324373A patent/NZ324373A/en unknown
- 1996-12-19 US US09/091,748 patent/US6197761B1/en not_active Expired - Fee Related
- 1996-12-19 PL PL96327629A patent/PL327629A1/xx unknown
- 1996-12-19 AP APAP/P/1998/001274A patent/AP9801274A0/en unknown
- 1996-12-19 HU HU9903707A patent/HUP9903707A3/hu unknown
-
1997
- 1997-06-26 TW TW086108975A patent/TW498072B/zh active
- 1997-06-27 PE PE1997000549A patent/PE87598A1/es not_active Application Discontinuation
-
1998
- 1998-06-19 OA OA9800089A patent/OA10701A/en unknown
- 1998-06-23 IS IS4781A patent/IS4781A/is unknown
- 1998-06-25 MX MX9805181A patent/MX9805181A/es unknown
- 1998-06-26 NO NO19983004A patent/NO311022B1/no not_active IP Right Cessation
- 1998-07-13 BG BG102625A patent/BG102625A/xx unknown
- 1998-12-16 HK HK98113683A patent/HK1012193A1/xx not_active IP Right Cessation
-
2000
- 2000-10-04 GR GR20000402254T patent/GR3034564T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE87598A1 (es) | Derivados de lactona de 17�-carboxi, carbotio y amida androstano | |
| TR200103095T2 (tr) | Renin engelleyiciler. | |
| EA200301094A1 (ru) | Аминопроизводные как ингибиторы протеазы | |
| ATE30021T1 (de) | Indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte. | |
| ATE119528T1 (de) | Alkoxy-substituierte dihydrobenzopyran-2- carbonsäuren und derivate davon. | |
| ATE460394T1 (de) | 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten | |
| EA200100983A1 (ru) | Производные 13-метилэритромицина | |
| DK71780A (da) | Fremgangsmaade til fremstilling af difenylhydantoinderivater | |
| EA200200108A1 (ru) | Производные стрептограминов, способ их получения и композиции на их основе | |
| DK0879231T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler | |
| YU5199A (sh) | Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija | |
| FI831431A0 (fi) | Bensotiazolinfoereningar | |
| DK0891346T3 (da) | Dihydrobenzofuranforbindelser, der er nyttige som antiinflammatoriske midler | |
| RU2004130284A (ru) | Антипаразитарные производные артемизинина (эндопероксиды) | |
| DE60030300D1 (de) | Topische behandlung zur vorbeugung von augeninfektionen | |
| KR880008810A (ko) | [벤조-1,2,4-티아디아진]-1,1-디옥사이드 용해 조성물 | |
| NO983527L (no) | Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler | |
| NO150436C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenylamino-imidazolin-derivater | |
| ATE113045T1 (de) | Alkoxy-substituierte dihydrobenzopyran-2- carbonsäure und deren derivate. | |
| KR890005094A (ko) | 치환된 3-아미노시드논이민, 이의 제조방법 및 이의 용도 | |
| DE3784913D1 (de) | Eicosattraynsaeureamide, ihre verwendung in der arzneimittelkunde und kosmetika, ihre herstellung und verfahren zur herstellung von eicosattraynsaeure. | |
| EA199800062A1 (ru) | Новые гетероциклические соединения для лечения боли и их применение | |
| PE20001494A1 (es) | Derivados de ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica | |
| KR910700236A (ko) | 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도 | |
| DE60208347D1 (de) | Verwendung von "xylyloxy alkyl amines" für die Behandlung von Tinnitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |